Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs - - APOE program added to ...

Alzheimer's disease is the most common type of dementia. All types of dementia involve a gradual loss of functions such as ...

At June 30, 2025, the Company's cash and cash equivalents were $695.6 million, after payment of $276.4 million for the Evergreen Theragnostics, Inc. (“Evergreen”) acquisition, which closed early in ...